This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Kind Pharmaceutical. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Biao Deng: Innovator in Indolizine Derivatives
Introduction
Biao Deng is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on indolizine derivatives. With a total of 4 patents to his name, Deng's innovations are paving the way for advancements in medical applications.
Latest Patents
Deng's latest patents focus on indolizine derivatives and their application in medicine. These inventions disclose novel substituted indolizine derivatives, which can include isotopically labeled compounds, optical isomers, geometric isomers, tautomers, and various mixtures of isomers. Additionally, these compounds can be presented as pharmaceutically acceptable salts or prodrugs. The significance of these inventions lies in their potential use in medical treatments, showcasing Deng's commitment to improving healthcare through innovative chemistry.
Career Highlights
Biao Deng is currently associated with Kind Pharmaceutical, where he continues to develop his research and inventions. His work has garnered attention in the pharmaceutical industry, contributing to the advancement of medicinal compounds.
Collaborations
Deng collaborates with notable colleagues, including Dong Liu and Dongdong Chen. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Biao Deng's contributions to the field of medicinal chemistry, particularly through his work on indolizine derivatives, highlight his role as an influential inventor. His ongoing research and collaborations promise to lead to significant advancements in medical applications.